Cormedix (CRMD) Stock Highlights

9.96 | -3.58%

2024-11-23 04:22:47

Cormedix Inc is a biopharmaceutical company that focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. It has been in-licensed to develop and commercialize Neutrolin, which is a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings such as hemodialysis, total parenteral nutrition, and oncology. The Neutrolin product is designed to target unmet medical needs.

Statistics

Range Today

9.93 10.37

Volume Today 879.1K

Range 1 Year

2.89 13.85

Volume 1 Year 182M

Range 3 Year

2.57 13.85

Volume 3 Year 396.69M

Range 10 Year

0.85 52

Volume 10 Year 957.7M

Highlights

Market Capitalization 703.86M (small)

Floating Shares 60.11M

Current Price 9.96

Price To Earnings -12.29

Price To Revenue 53.69

Price To Book 11.44

Earnings Per Share -0.87

Payout Ratio 0%

Performance

Latest -3.58%

1 Month -11.47%

3 Months +98.8%

6 Months +96.84%

1 Year +181.36%

3 Years +90.44%

5 Years +57.59%

10 Years +32.8%

Benchmarks

Market Capitalization

231 / 368

Gross Profits

149 / 278

Total Revenue

279 / 300

Total Rank

93 / 368

Free Cashflow

136 / 352

Performance 5 years

76 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.